Avricore Health Stock Today
| AVCR Stock | CAD 0.04 0.01 11.11% |
PerformanceVery Weak
| Odds Of DistressLow
|
Avricore Health is selling for under 0.04 as of the 19th of March 2025; that is 11.11 percent decrease since the beginning of the trading day. The stock's lowest day price was 0.04. Avricore Health has about a 23 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 19th of December 2024 and ending today, the 19th of March 2025. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | Category Healthcare | Classification Health Care |
Avricore Health Inc. manufactures and sells over-the-counter products in Canada. Avricore Health Inc. was founded in 1996 and is headquartered in Vancouver, Canada. AVRICORE HEALTH operates under Drug Manufacturers - Specialty Generic classification in Canada and is traded on TSX Venture Exchange.. The company has 101.29 M outstanding shares of which 4.86 K shares are presently shorted by private and institutional investors with about 0.05 days to cover all short positions. More on Avricore Health
Moving together with Avricore Stock
Moving against Avricore Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Avricore Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Avricore Health's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Avricore Health or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Thematic Ideas | (View all Themes) | ||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Management, Management, Health Care, Biotechnology, Drug Manufacturers - Specialty & Generic, Healthcare (View all Sectors) | ||||
Avricore Health's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Avricore Health's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsAvricore Health can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Avricore Health's financial leverage. It provides some insight into what part of Avricore Health's total assets is financed by creditors.
| |||||
Avricore Health (AVCR) is traded on TSX Venture Exchange in Canada and employs 5 people. Avricore Health is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 4.56 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Avricore Health's market, we take the total number of its shares issued and multiply it by Avricore Health's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Avricore Health operates under Biotechnology sector and is part of Health Care industry. The entity has 101.29 M outstanding shares of which 4.86 K shares are presently shorted by private and institutional investors with about 0.05 days to cover all short positions.
Avricore Health has accumulated about 122.09 K in cash with 660.4 K of positive cash flow from operations.
Check Avricore Health Probability Of Bankruptcy
Ownership AllocationAvricore Health holds a total of 101.29 Million outstanding shares. Avricore Health shows 10.19 percent of its outstanding shares held by insiders and 0.0 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Avricore Ownership Details
Avricore Health Risk Profiles
Although Avricore Health's alpha and beta are two of the key measurements used to evaluate Avricore Health's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 4.08 | |||
| Standard Deviation | 6.32 | |||
| Variance | 39.95 | |||
| Risk Adjusted Performance | (0.06) |
Avricore Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Avricore Health without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Latest Portfolios Now
Latest PortfoliosQuick portfolio dashboard that showcases your latest portfolios |
| All Next | Launch Module |
Avricore Health Corporate Management
Elected by the shareholders, the Avricore Health's board of directors comprises two types of representatives: Avricore Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Avricore. The board's role is to monitor Avricore Health's management team and ensure that shareholders' interests are well served. Avricore Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Avricore Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Rodger Seccombe | Head Director | Profile | |
| Hector Bremner | CEO Director | Profile | |
| Will Seccombe | Communications Advisor | Profile | |
| CPA CFO | CFO Sec | Profile | |
| Allan Shapiro | Mang Devel | Profile |
Additional Tools for Avricore Stock Analysis
When running Avricore Health's price analysis, check to measure Avricore Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avricore Health is operating at the current time. Most of Avricore Health's value examination focuses on studying past and present price action to predict the probability of Avricore Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avricore Health's price. Additionally, you may evaluate how the addition of Avricore Health to your portfolios can decrease your overall portfolio volatility.